跳至主要内容
临床试验/NCT02575664
NCT02575664已完成4 期

Effects of Low Dose Buprenorphine on Recovery After Hip or Knee Arthroplasty

Kuopio University Hospital1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2012年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
160
试验地点
1
主要终点
Prolonged pain after arthroplastic surgery

研究概览

简要总结

Buprenorphine is a highly lipophilic thebaine derivative that appears to have high affinity for mu-, kappa-, and delta-opioid receptors and low affinity for opioid receptors like 1 -receptors. It acts as a partial agonist at the mu-opioid and as a partial agonist/antagonist at the kappa-opioid, and as an antagonist at the delta opioid receptors. Buprenorphine has up to two-fold duration of action and it is approximately 30-fold more potent when compared to morphine.

Pain is a common problem in patients coming to joint arthroplastic surgery. Buprenorphine low dose patches are recommended for treatment of moderate pain for example osteoarthritis pain. It is known that well treated pain even preoperatively may prevent prolonged postsurgical pain.

In the present study the effects of low dose buprenorphine on postoperative pain and recovery were assessed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • no pregnancy/lactation, reliable contraception before menopause
  • elective knee or hip arthroplasty surgery
  • BMI (=body mass index) 18-35 kg/m2
  • obtained informed consent

排除标准

  • buprenorphine medication
  • allergy to study drugs• ikä < 18 tai >75 years
  • BMI <18 tai>35 kg/m2
  • weight below 50 kg
  • Other contraindication for the study drug

研究组 & 干预措施

Buprenorphine

Experimental

Buprenorphine 5 microg/h/7days patch

干预措施: Buprenorphine (Drug)

Placebo

Placebo Comparator

Placebo patch

干预措施: Placebo (Drug)

结局指标

主要结局

Prolonged pain after arthroplastic surgery

时间窗: from time from drug patch administration up to one year

Brief pain inventory

Pain relief

时间窗: time from drug patch administration up to five weeks

Brief pain inventory

次要结局

未报告次要终点

研究者

发起方
Kuopio University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Merja Kokki

MD, PhD

Kuopio University Hospital

研究点 (1)

Loading locations...

相似试验